Lifecore Biomedical
LFCR
LFCR
89 hedge funds and large institutions have $252M invested in Lifecore Biomedical in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 34 increasing their positions, 35 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $279M → $252M (-$26.9M)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
Holders
89
Holding in Top 10
5
Calls
$5K
Puts
–
Top Buyers
| 1 | +$1.18M | |
| 2 | +$1.15M | |
| 3 | +$998K | |
| 4 |
ICM
ISZO Capital Management
New York
|
+$643K |
| 5 |
CSC
Cove Street Capital
El Segundo,
California
|
+$494K |
Top Sellers
| 1 | -$2.96M | |
| 2 | -$2.22M | |
| 3 | -$984K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$581K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$577K |